We obtained two human cDNA clones encoding phosphatidic acid phosphatase (PAP) isozymes named PAP-2a (M r ‫؍‬ 32,158) and -2b (M r ‫؍‬ 35, 119), both of which contained six putative transmembrane domains. Both enzymes were glycosylated and cleaved by N-glycanase and endo-␤-galactosidase, thus suggesting their post-Golgi localization. PAP-2a and -2b shared 47% identical sequence and were judged to be the human counterparts of the previously sequenced mouse 35-kDa PAP(83% identity) and rat Dri42 protein (94% identity), respectively. Furthermore, the sequences of both PAPs were 34 -39% identical to that of Drosophila Wunen protein. In view of the functions ascribed to Wunen and Dri42 in germ cell migration and epithelial differentiation, respectively, these findings unexpectedly suggest critical roles of PAP isoforms in cell growth and differentiation. Although the two PAPs hydrolyzed lysophosphatidate and ceramide-1-phosphate in addition to phosphatidate, the hydrolysis of sphingosine-1-phosphate was detected only for PAP-2b. PAP-2b was expressed almost ubiquitously in all human tissues examined, whereas the expression of PAP-2a was relatively variable, being extremely low in the placenta and thymus. In HeLa cells, the transcription of PAP-2a was not affected by different stimuli, whereas PAP-2b was induced (up to 3-fold) by epidermal growth factor. These findings indicate that despite structural similarities, the two PAP isozymes may play distinct functions through their different patterns of substrate utilization and transcriptional regulation.
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Phosphatidic acid phosphatase (PAP)
1 (EC 3.1.3.4) supplies diacylglycerol (DG) in glycerolipid biosynthesis by dephosphorylating phosphatidic acid (PA) (1) . Since both DG (2) and PA (3) are potent signaling molecules, PAP plays an important role in cellular signal transduction in addition to lipid biosynthesis (4) . In signaling systems mediated by phospholipase D (5), liberated PA is generally converted, albeit to different extents, to DG by the action of PAP (6 -8) , thus suggesting that PAP contributes to the control of the relative balance of the two lipid second messengers.
There exist two forms of mammalian PAP that can be distinguished with respect to subcellular localization and enzymologic properties (9) . So far, distinct functions have been ascribed to the two forms of PAP. The type 1 PAP, a Mg 2ϩ -dependent and N-ethylmaleimide-sensitive enzyme, is considered to be primarily involved in lipid synthesis based on its translocation from the cytosol to microsomes upon stimulation of cellular triacylglycerol synthesis (10 -12) . In this context, a recent work showed using a novel enzyme inhibitor that the type 1 PAP indeed participated in triacylglycerol synthesis in mouse macrophages (13) . On the other hand, the type 2 PAP, a Mg 2ϩ -independent and N-ethylmaleimide-insensitive enzyme, has been postulated to participate in cellular signal transduction mediated by phospholipase D. The finding that the activities of the type 2 PAP and phospholipase D were decreased in a coordinate manner in transformed fibroblasts (14) is consistent with the role of this isoform in signal transduction. However, such distinct functions ascribed to the PAP isoforms need to be further studied, since there are several reports describing the participation of the type 1 rather than the type 2 PAP in signal transduction occurring in, for example, polymorphonuclear leukocytes stimulated with inflammatory substances (15) and EGF-stimulated A431 cells (16) .
A novel aspect of the function of the type 2 PAP has recently been disclosed by its broad substrate specificity. The enzyme purified from rat liver could hydrolyze ceramide-1-phosphate and sphingosine-1-phosphate in addition to PA and lyso-PA (17) . Since ceramide, sphingosine, and their phosphorylated derivatives are known to serve as signaling molecules (18 -20) , the type 2 PAP can be involved in the metabolic processing of lipid mediators derived from both glycerolipids and sphingolipids. Furthermore, the type 2 PAP from rat liver has been described to be capable of hydrolyzing DG pyrophosphate (21), a novel phospholipid with a potential signaling function at least in plants (22) .
Despite the apparent importance of PAP as noted above, relatively little has been known for the molecular structure of this enzyme. After several attempts of enzyme purification of the type 2 PAP (23-26), we have finally succeeded in the cDNA cloning of a mouse 35-kDa enzyme, which was confirmed to be the type 2 plasma membrane-bound PAP (27) . The cloned enzyme is a novel glycoprotein exhibiting a channel-like structure with six putative transmembrane domains. We soon noticed (28) that the amino acid sequence of the mouse PAP is 34 and 48% identical to those of Drosophila Wunen protein (29) and rat Dri42 protein (30) , respectively. The Wunen and Dri42 have been cloned as gene products involved in the regulation of germ cell migration (29) and in epithelial differentiation (30) , respectively. However, it is not determined whether the Wunen and Dri42 possess the PAP catalytic activities. The rat Dri42 was described to reside in the endoplasmic reticulum (30) , whereas the mouse 35-kDa PAP (with a closely related structure) was confirmed to localize in the plasma membranes (27) . Furthermore, the purification of the type 2 PAP yielded enzyme proteins with variable molecular sizes (24 -26) , thus suggesting the presence of multiple forms of the type 2 PAP. The systematic characterization of the type 2 PAP isozymes should help to understand the biological implications of this novel type of phosphatase. We thus attempted to clone the type 2 PAP isozymes. We have cloned two human PAP-2 isozymes designated 2a and 2b, which happened to be the human counterparts of the mouse 35-kDa PAP and rat Dri42, respectively. The two PAP isozymes showed distinct properties despite their structural similarities, suggesting their different functions.
EXPERIMENTAL PROCEDURES
Materials-The sources of most of the materials have been described previously (23, 27, 31 Escherichia coli DG kinase was obtained from Calbiochem, and the protein assay kit was from Pierce. N-Glycanase was obtained from New England Biolabs, and sialidase and endo-␤-galactosidase were the products of Seikagaku (Tokyo, Japan). The rabbit anti-calnexin antibody has been described (32) . The rhodamine-conjugated anti-rabbit IgG antibody was purchased from Jackson ImmunoResearch Laboratories Inc., and anti-HA epitope tag antibody, 12CA5, was obtained from Boehringer Mannheim. Several cell lines, 293, HeLa, and HepG2, were cultured in Dulbecco's modified Eagle's minimum essential medium supplemented with 10% fetal bovine serum (Life Technologies, Inc.) as described previously (27, 31) .
Preparation of Lipid Substrates-Radiolabeled PA, lyso-PA, and ceramide-1-phosphate were prepared by incubating dioleoylglycerol, monoolein, and ceramide, respectively, with [␥-32 P]ATP and E. coli DG kinase (33) as described previously (23, 27) . [ 32 P]Sphingosine-1-phosphate was prepared by acid hydrolysis of labeled ceramide-1-phosphate as described by Gomez-Munoz et al. (34) . The labeled lipids were purified by thin layer chromatography and quantitated by phosphate analysis and radioactivity determination. Nonlabeled ceramide-1-phosphate was prepared by phospholipase D treatment of sphingomyelin as described by Imamura and Horiuti (35) .
Lipid Phosphate Phosphatase Assay-The specific radioactivities of the labeled substrates were 5,000 -20,000 cpm/nmol, and the substrates were added as Triton X-100 mixed micelles. The phosphatase activities hydrolyzing different substrates were measured under the same conditions as described previously (23, 27) . The reaction mixture (50 l) contained 50 mM Tris-HCl (pH 7.5), 0.2 mM labeled lipids, 3.2 mM Triton X-100, 1 mM EDTA, bovine serum albumin (1 mg/ml), and enzyme. Except for incubation with sphingosine-1-phosphate, the reaction was continued for 5 min at 37°C, and the liberation of water-soluble 32 P i was determined by liquid scintillation counting as described before (23, 27) . The incubation with sphingosine-1-phosphate was continued for 20 min, and the reaction was stopped with 10 l of concentrated formic acid as described by Waggoner et al.(17) . In this case, the released 32 P i was separated by thin layer chromatography (17) . All reaction rates were proportional to the amounts of enzyme protein and incubation time and were usually done in triplicates, the results of which differed Ͻ5%.
PCR Amplification of Human cDNAs Encoding PAP Isozymes-We initially searched GenBank TM data base for the human cDNA sequences encoding proteins homologous to the mouse PAP (27) . We found two representative cDNA fragments (accession numbers H68363 and N68923) encoding the partial C-terminal amino acid sequences, which were distinct from each other but similar to the corresponding regions of the mouse PAP. We presumed that these cDNAs represented the clones encoding PAP isozymes and tentatively designated the predicted proteins as PAP-2a and -2b. To obtain the cDNAs containing the complete coding regions for the putative PAP isozymes, we made use of the RACE-PCR method using Marathon cDNA amplification kit from CLONTECH. We first synthesized oligoprimers HPa0 and HPb0 based on the sequences unique to the PAP-2a (accession number H68363) and PAP-2b (accession number N68923) cDNAs, respectively. Using these primers, the first-strand cDNAs were synthesized from 2 g of total RNA prepared from HepG2 cells as described previously (31) . The first-strand cDNAs thus synthesized were subjected to the first round of RACE-PCR using other nested primers, each specific for PAP-2a and -2b (HPa1 and HPb1, respectively) following the manufacturer's protocol. The amplified fragments (922 bp for PAP-2a and 820 bp for PAP-2b) were gel-purified, subcloned into pBluescript IISKϩ (Stratagene), and sequenced using ABI PRISM system (Perkin-Elmer). The next and final round of RACE-PCR amplification of the two cDNAs was then performed using specific primers (HPa2 and HPb2) synthesized on the basis of the determined nucleotide sequences. The RACE-PCR amplification described resulted in the sequencing of 937 and 1024 bp of cDNAs containing the complete coding regions for PAP-2a and PAP-2b, respectively. In the final experiments, we synthesized the sense-directed primers, HPa3 and HPb3, based on the 5Ј-most sequences of the cDNAs sequenced for PAP-2a and 2b as described above. The full-length cDNAs encoding PAP-2a and PAP-2b were then obtained by reverse transcriptase-PCR from 2 g of total HepG2 RNA using Superscript preamplification system (Life Technologies, Inc.). In this case amplification was done as described previously (31), using the primer sets of HPa1-HPa3 and HPb1-HPb3 for PAP-2a and PAP-2b, respectively. The resultant PCR products were subcloned into pBluescript II SK at the EcoRV site, and the sequences of the two cDNAs were confirmed by sequencing five independent clones for each. DNA sequences were analyzed and aligned as described previously (27, 36) . The primers used in these experiments are summarized as follows (5Ј 3 3Ј). The corresponding nucleotide numbers in the respective cDNA clones are shown in the parentheses. For amplification of PAP-2a cDNA: HPa0, AAGGCTTG-TACACCAGGAAGAAAG (for synthesizing the first-strand cDNA); HPa1, AACAGGCCAGCTTCAGGTGGGCAC (937-914); HPa2, GTA-AGGGTACTTGATGGACTCATC (194 -171); and HPa3, ACCGCAGCT-CAGTCCATCGCCCTTG . In the case of sequencing PAP-2b: HPb0, AGTCGGGCAAAAGTTTTTCCCTAC (for synthesizing the first-strand cDNA); HPb1, TACTGTCTGATGAGATTGGAGAGC (1024 -1001); HPb2, TCACCAGTTTTCAGTGGGTACTTG (248 -225); and HPb3, AGCGCCATGCAAAACTACAAGTAC .
Construction of Expression Plasmids-The PAP cDNAs were subcloned into pREP9 (Invitrogen) at the HindIII-BamHI site as described previously (27) . To express PAP isozymes as GFP-fusion proteins, two primers for each cDNA were synthesized for PCR amplification. In the case of PAP-2a, the sense primer, HPa-N, 5Ј-GGCAGCCCGGGCTAG-CACCATGTTCGACAAGAC-3Ј (corresponding to nucleotides 29 -61) was designed to generate a NheI site (underlined). The antisense primer, HPa-C, 5Ј-GCACCCTGCTGCGTCGACAGGCTGGTGATTG-3Ј (nucleotides 917-887) was designed to introduce a SalI site and also to destroy the termination codon of PAP-2a (underlined). PCR amplification was performed as described previously (31) using the two primers and the PAP-2a cDNA in pBluescript as a template. The amplified fragment was digested with NheI and SalI and subcloned into the plasmid pEGFP-3N (CLONTECH) at the corresponding site. A similar strategy was adopted for the construction of the expression plasmid of PAP-2b-GFP fusion protein. In this case, the PCR mixture contained the sense primer, HPb-N (5Ј-CGATAAGCTTGCTAGCGCCATG-CAAAAC-3Ј, corresponding to nucleotides 1-15 in the PAP-2b cDNA, restriction site and mutated nucleotides underlined), the antisense primer, HPb-C (5Ј-AGGAGGTGGGTGCTCGAGACATCATGTTGTG-3Ј, nucleotides 958 -928), and the PAP-2b clone in pBluescript. The amplified fragment was digested with NheI and XhoI and subcloned into the corresponding site of the plasmid pEGFP-3N.
The plasmids for expression of the two PAPs each with an HA epitope tag (YPYDVPDYA) at the C terminus (PAP-HA) were prepared from the pEGFP-3N expression vectors constructed as described above. For this purpose, we prepared an adaptor coding for a HA tag as follows. The two oligonucleotides, 5Ј-TCGAGTATCCATATGATGTTCCAGAT-TATGCTCTCGACGCGCGGGCC-3Ј and 5Ј-CGCGCGTCGAGAGCATA-ATCTGGAACATCATATGGATAC-3Ј at 50 M each were dissolved in the annealing buffer containing 50 mM Tris-HCl (pH 7.4), 10 mM MgCl 2 , and 100 mM NaCl. The mixture was heated at 90°C for 2 min and cooled slowly to 50°C at the rate of 1°C/min. The annealed adaptor was inserted into the PAP-2a/pEGFP-3N clone at the SalI-ApaI site. The vector expressed PAP-2a with the C-terminal HA tag with 14 additional vector-derived residues. The expression vector for PAP-2b with a HA tag was constructed by a similar protocol. In this case, PAP-2b was expressed with the additional 21 residues including the tag sequence.
Expression of PAP Isozymes-pREP9 harboring PAP isozymes (2 g/35-mm dish) was transfected to 293 cells as described previously (27) . After 3 days, cells were homogenized in the lysis buffer (27) , and membrane fractions were prepared for assaying various phosphatase activities.
Posttranslational Processing of HA-tagged PAP Isozymes-293 cells (40 -60% confluence) cultured on 4-well plates (Nunc) were transfected with the expression plasmids (1.5 g/well) harboring PAP-2a-HA and PAP-2b-HA. After 2 days, cells were washed with methionine-free culture medium and pulse-labeled with [ 35 S]methionine(40 Ci/ml) for 15 min. The cells were then chased for up to 45 min in the medium supplemented with 2 mM methionine as described (32) . The chased cells were lyzed by sonication in 150 l/well of the lysis buffer containing 1% Triton X-100, 200 mM KCl, 5 M each of leupeptin and pepstain, and 25 mM triethanolamine-acetic acid (pH 7.2). The lysates were pretreated for 20 min on ice with 10 l of 20% (w/v) formalin-fixed Staphylococcus aureus (Sigma) and 2 l of 10% bovine albumin. The pretreated lysates were centrifuged for 5 min at 12,000 ϫ g, and the supernatants were incubated for 60 min with the anti-HA tag antibody (0.5 g/ml). The immunoprecipitates prepared (27) were denatured by heating at 65°C for 10 min in 20 l of 10 mM Tris-HCl (pH 7.4) containing 1% Triton X-100. After denaturation, the samples were treated with N-glycanase (10 units) or sialidase (1 milliunit) with or without 1 milliunit of endo-␤-galactosidase according to the supplier's protocol. The mixture also contained 1 mM o-phenanthroline as a protease inhibitor and was incubated for 6 h at 37°C. After enzymic treatments, the samples were analyzed by SDS-12.5% PAGE (37) . The radioactive bands were visualized by a BAS 2000 image analyzer (Fuji).
Analysis of PAP mRNAs in Stimulated HeLa Cells-Confluent HeLa cells in 35-mm dishes were starved for 40 h in the serum-free medium containing 0.1% bovine serum albumin. The cells were then cultured in the presence of 0.5 mM H 2 O 2 or EGF(50 ng/ml) for up to 24 h. Total RNA was prepared from the treated cells as described previously (31) . Reverse transcriptase-PCR amplification of the PAP mRNAs was done using Superscript preamplification system (Life Technologies, Inc.) following the manufacturer's protocol. The single-stranded cDNA primed by oligo(dT) was obtained from 2 g of total RNA (31). The following PCR used 5 M each of the specific primer sets: HPa3 (nucleotides and HPa4 (5Ј-ATAGTGGCTATGTAGTTATTCCTG-3Ј, nucleotides 340 -317) for PAP-2a; and HPb3 (1-24) and HPb4 (CACAGAGCA-CAGCGTCATTTATTG, 274 -251) for PAP-2b amplification. The amplification using glyceraldehyde-3-phosphate dehydrogenase control amplimer sets (CLONTECH) was also done as a control. Amplification reaction was done on a GeneAmp PCR System 2400 (Perkin-Elmer Corp.) at 94°C for 20 s, 60°C for 30 s, and 72°C for 2 min for the cycles that were preliminarily determined to yield linear amplification of PAP mRNAs (31): 22 cycles for PAP-2a, 23 cycles for PAP-2b, and 14 cycles for glyceraldehyde-3-phosphate dehydrogenase. The aliquots of the PCR products were resolved by 1.8% agarose gel electrophoresis and analyzed by Southern blotting as described previously (31) . The probes were obtained by PCR amplification as described above using the cDNAs of PAP-2a and PAP-2b in pBluescript and labeled with 32 P by random priming.
Northern Hybridization-The human multiple tissue Northern blot (CLONTECH) was used according to the supplier's protocol. The labeled probes were the same as described for reverse transcriptase-PCR.
RESULTS
cDNA Cloning of Two Human PAP Isozymes-As already noted in our previous paper (27) , the mouse 35-kDa PAP sequence gave, when searched for GenBank TM data base, several homologous sequences such as Caenorhabditis elegans T28D9.3p and Saccharomyces cerevisiae D9719.9p. Although these homologous proteins had no assigned functions, the alignment of the deduced amino acid sequences disclosed several conserved regions sharing 26 -60% identical sequences with the mouse PAP. We additionally noted that a part of the mouse PAP sequence was significantly similar to the amino acid clusters conserved among bacterial nonspecific acid phosphatases (Ref. 28 and under "Discussion"). Based on these findings, we selected the amino acid sequence of Cys-153-Gln-234 of the mouse PAP (27) as a query sequence and repeated the homology search using TBLASTN program, resulting in the detection of several human cDNA fragments encoding similar amino acid sequences. These partial cDNAs could be aligned to yield two independent sequences (not shown). The first sequence was 626 bp long and encoded the C-terminal 161 residues. Since the encoded sequence was 81% identical to the corresponding region of the mouse PAP sequenced first (27), we designated the gene product PAP-2a. The second cDNA was 419 bp long and encoded the C-terminal 89 residues, which were only 38% identical to those of the mouse PAP. We thus designated the putative protein PAP-2b.
To obtain the full-length cDNAs containing the complete coding regions for the putative PAP-2a and -2b, we performed the two-step amplification of cDNAs from HepG2 RNA as described under "Experimental Procedures." The amplified cDNAs encoding PAP-2a and -2b were 937 and 1024 bp long, respectively (not shown), and contained the open reading frames at nucleotides 48 -902 and 7-942, respectively. In both cDNAs, we recognized neither in-frame stop codons in the 5Ј-noncoding regions nor polyadenylation sites in the 3Ј-flanking regions. We thus could not deny the possibility that the cDNAs obtained did not cover the whole coding regions for the two putative PAPs. However, the repeated 5Ј-RACE procedures failed to further extend the cDNAs, and we judged from the similarities of the two sequences that the cDNAs we obtained contained the full-length coding regions as described below.
As shown in Fig. 1 , PAP-2a and -2b consisted of 284 and 311 amino acid residues with the calculated M r of 32,158 and 35,119, respectively. The sequences of the two putative PAPs are similar to but distinctly different from each other, sharing only 47% identical sequence. PAP-2a and the mouse PAP previously sequenced are highly similar to each other, sharing overall 83% identical sequence, thus indicating that PAP-2a is a human homolog of the mouse PAP. In this context we noted that the N-terminal 25 residues of PAP-2a are the same as have been determined chemically for the purified porcine thymus 35-kDa PAP (27) . Unexpectedly, PAP-2b shares 94% identical sequence with rat Dri42 protein (30) . Dri42 has been cloned as the gene product up-regulated during the epithelial differentiation in rat small intestine (30) . We thus cloned a human counterpart of rat Dri42 in an attempt to characterize PAP isozymes. In addition, Drosophila Wunen protein, which was discovered as a repulsive gene product responsible for regulating the germ cell migration in the embryo (29) , shares 39 and 34% identical sequences with PAP-2a and PAP-2b, respectively. The four mammalian PAP homologs contained a single conserved N-glycosylation site, and PAP-2a and -2b were indeed confirmed to be glycoproteins as will be described later. These proteins contained six transmembrane regions as revealed by the hydropathy plot (not shown). Since the transmembrane disposition of the rat Dri42 protein was characterized in detail (30) , the sequences of these PAPs could be tentatively classified into intracellular, transmembrane, and extracellular regions as depicted in Fig. 1 .
Enzymic Properties of the Expressed PAP Isozymes-To confirm that the two cDNAs encoded the PAP enzymes, the cDNAs were subcloned into the expression vector, pREP9, and transfected to 293 cells. The membrane fractions obtained 3 days after transfection were subjected to the enzyme assay as described under "Experimental Procedures." The membranes prepared from cells transfected with the PAP-2a and -2b cDNAs showed 9-and 7-fold higher PAP activities, respectively, when compared with the cells transfected with the control vector alone (Fig. 2, panel A) . In this case no changes of the enzyme activity were detected for the cytosolic fractions. We also confirmed that both PAP-2a and -2b activities were inhibited by propranolol and sphingosine, very similarly as described for the purified porcine thymus PAP (23). Since both PAP-2a and -2b activities were insensitive to N-ethylmaleimide and independent of Mg 2ϩ (not shown), the two PAP isozymes were suggested to be the type 2, plasma membrane-bound enzymes (9).
Waggoner et al. (17) recently reported that the type 2 PAP purified from rat liver dephosphorylates lyso-PA, ceramide-1-phosphate, and sphingosine-1-phosphate in addition to PA. Furthermore, the same enzyme preparation was described as capable of dephosphorylating DG pyrophosphate (21) . In view of such a broad substrate specificity described for the type 2 PAP, we tested various substrates for the two PAP isozymes expressed in 293 cells (Fig. 2) . The activity of PAP-2a to lyso-PA was particularly high (15-fold increase from the control), and a significant increase of ceramide-1-phosphate-hydrolyzing activity (2.5-fold increase) was also observed for this isozyme. In contrast, the transfection of PAP-2a failed to increase the activity toward sphingosine-1-phosphate (Fig. 2, panel D) . The transfection of the PAP-2b cDNA, on the other hand, increased the activities to lyso-PA, ceramide-1-phosphate, and sphingosine-1-phosphate by 4-, 4-, and 26-fold over the control membranes. In these experiments, various lipid phosphate phosphatase activities were variably increased due to the different levels of the endogenous activities. All enzyme assays were done simply under the fixed reaction conditions, which gave maximum activities. Although detailed kinetic analysis is needed, it is clear that the substrate specificities of the two PAPs cloned are distinct from each other and that dephosphorylation of sphingosine-1-phosphate by PAP-2a occurs to a negligible extent, if any. In this respect, the properties of PAP-2b are more similar to those of rat liver enzyme (17) , which degrades all of these substrates at similar rates.
The Expression Patterns of the PAP Isozymes-We first studied the tissue-dependent expression of the two PAPs using specific probes and the commercial multiple tissue Northern blot human blots. The sizes of mRNAs of PAP-2a and -2b were estimated to be 1.74 and 1.4 kb, respectively (Fig. 3) . We noted clearly distinct distribution patterns of the two mRNAs. The PAP-2b mRNA was detected in all tissues examined, indicating a ubiquitous expression of this PAP isozyme. PAP-2a expression, on the other hand, was markedly variable, depending on the tissues, being highly abundant in the prostate but undetectable in the thymus, placenta, and leukocytes.
We previously showed that the mouse 35-kDa PAP, a homolog of PAP-2a, was highly similar to the hic53 gene product 
FIG. 3. Northern hybridization analysis of the PAP isozymes.
The multiple human tissue Northern blots (CLONTECH) were hybridized with 32 P-labeled probes specific to each PAP and the control actin probe as described under "Experimental Procedures." 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, prostate; 12, testis; 13, ovary; 14, small intestine; 15, colon; 16, peripheral blood leukocytes. hPAP, human PAP; kb, kilobases. described to be induced upon H 2 O 2 treatment of mouse osteoblastic cell line (38) . We were thus interested to see if the expression of the two PAPs was affected in cells treated with various agonists, including H 2 O 2 . For this purpose, quiescent HeLa cells were exposed to H 2 O 2 , and the time-dependent changes of the levels of PAP mRNAs were estimated by reverse transcriptase-PCR as shown in Fig. 4 . We found that the expression of both PAPs was not affected significantly by the treatment with H 2 O 2 . Such negative results have been obtained using different concentrations of H 2 O 2 (0 -5 mM) and using other cells like HepG2 and PC3 (not shown). Similarly, the expression of the two PAPs was not affected by a variety of other agonists, including tumor necrosis factor ␣ (at 50 ng/ml), tumor growth factor ␤1 (2.5 ng/ml), phorbol myristate acetate (200 nM), and calcium ionophore A23817(100 nM) (not shown). However, EGF caused an exceptional sustained increase (up to 3-fold) of the mRNA of PAP-2b but not of PAP-2a as shown in Fig. 4 . In these experiments we observed a gradual increase of the PAP-2b mRNA during the control incubations that was reproducible. The reason for this phenomenon remains unknown. The results of Northern blotting and reverse transcriptase-PCR analysis of cellular mRNAs as described above suggest that the levels of expression of PAP-2a and 2b are regulated by distinct mechanisms.
Posttranslational Processing of the PAP Isozymes-The mouse 35-kDa PAP has already been shown to be a glycoprotein and possess two consensus N-linked glycosylation sites (27) . The alignment of sequences of four mammalian PAP homologs achieved in the present study (Fig. 1) showed that these enzymes have a single (instead of two) N-glycosylation site conserved. It is thus quite likely that PAP-2a and -2b are glycosylated at Asn-142 and Asn-170, respectively. To assess the posttranslational processing of the two PAPs, 293 cells transfected with HA-tagged enzymes were pulse-labeled with [ 35 S]methionine, and anti HA epitope tag immunoprecipitates obtained from the chased cells were analyzed by SDS-PAGE (Fig. 5) . In these experiments, calculated molecular masses of epitope-tagged PAP-2a and -2b were estimated to be approximately 35 and 38 kDa, respectively. In the case of PAP-2a (Fig.  5A) , the labeled cells contained a major 41-and a minor 37-kDa bands before chase. During the chase periods, the 41-kDa band gradually decreased and was replaced with a diffuse 45-kDa species. When treated with N-glycanase, both 41-and 45-kDa bands shifted to 37 kDa. The migration of the 45-kDa diffuse band was slightly affected by sialidase treatment (Fig. 5A, lane  6) , and this band became 41 kDa when treated further with endo-␤-galactosidase. The sensitivity to endo-␤-galactosidase strongly suggests the presence of polylactosaminoglycans (39) . These findings indicate that the 37-kDa band is a nonglycosylated form and that the 41-kDa species contains a high mannose-type oligosaccharide. The diffuse 45-kDa should represent a mature form of PAP-2a containing an N-linked oligosaccharide modified by the addition of polylactosaminoglycan and sialic acids (39) . The same rationale could be applied to PAP-2b (Fig. 5B) . In this case, the 33-kDa band represents a nonglycosylated enzyme, and the 38-kDa species contains an N-linked high mannose-type sugar chain. The diffuse bands at 39 -44 kDa should be the mature forms of PAP-2b containing polylactosaminoglycans. It was noted that the oligosaccharide chain of PAP-2b was more heterogeneous than that of PAP-2a, as shown by the presence of at least 4 bands at 39 -44 kDa (Fig.   FIG. 4 . Reverse transcriptase-PCR analysis of the PAP expression in HeLa cells. A, quiescent HeLa cells were exposed for different periods as indicated to 0.5 mM H 2 O 2 or 50 ng/ml epidermal growth factor. The total cellular RNA (2 g) was subjected to reverse transcriptase-PCR in which 22, 23, and 14 cycles of PCR amplifications were done for PAP-2a, -2b, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), respectively. The PCR products were detected by Southern blotting using radiolabeled probes as described under "Experimental Procedures." The results are representative of twice-repeated experiments. hPAP, human PAP. B, relative signal intensities normalized with glyceraldehyde-3-phosphate dehydrogenase signals as determined by densitometric scanning of the autoradiograms. 
5B, lane 5).
In these experiments, the migration of the HAtagged enzymes upon SDS-PAGE was somewhat deviated from their expected molecular masses for unknown reasons. DISCUSSION We have cloned two human PAP isozymes, both of which can be classified as the type 2 enzymes. One isozyme, designated PAP-2b, was judged to be the human homolog of rat Dri42, sharing 94% identical sequence. The other isozyme, PAP-2a, was considered to be the human counterpart of the mouse 35 kDa PAP (27) , based on the sequence comparison. Rat Dri42 has been cloned as a gene induced upon epithelial differentiation in the small intestine (30) . It was also noted that the two human PAPs exhibit a significant similarity to Drosophila Wunen, which regulates the germ cell migration (29) . The sequencing of the mammalian PAPs thus unexpectedly disclosed important roles of the type 2 PAPs in basic biological functions such as cell migration, differentiation, and growth. Since the Dri42 protein is now confirmed to possess the PAP enzyme activity, it is highly likely that the Wunen also exerts its regulatory functions by catalyzing the dephosphorylation of PA and/or other lipid phosphates. One of the unresolved questions concerns the intracellular localization of Dri42 and PAP2b. Rat Dri42 was concluded to reside in the endoplasmic reticulum, based on the results of immunostaining of the endogenous protein in the small intestine and of the overexpressed fusion protein with chloramphenicol acetyltransferase (30) . Furthermore, the fusion protein obtained from the pulsechased cells did not acquire Golgi modification of its N-linked oligosaccharide (30) . In the case of PAP-2b, the sensitivity of its oligosaccharide chain to endo-␤-galactosidase (Fig. 5) at least indicates its post-Golgi localization (39) . In the experiments not shown, the intracellular distribution of both PAP-2a and -2b expressed in 293 cells as GFP-fusion proteins was distinct from that of the simultaneously stained calnexin, which is known to serve as a marker for the endoplasmic reticulum (40) . The results of the parallel experiments using PAP-2a, the mouse and porcine homologs of which have been confirmed to be plasma membrane-bound (27) , also support the plasma membrane localization of these enzymes. We thus do not know why the two almost identical proteins are different in their intracellular localization.
Although we failed to account for the discrepant localization of PAP-2b and Dri42, the transmembrane disposition of Dri42 characterized in detail (30) provides useful information on the shape and function of the mammalian type 2 PAPs. As has been depicted in Fig. 1 , the mammalian PAP can now be proposed to contain four intracellular segments, including both N-and C-terminal regions, six transmembrane regions, and three extracellular loops. Such a transmembrane disposition assigned to these molecules is reminiscent of channel proteins rather than lipid phosphatases, as has been discussed for Dri42. However, a novel phosphatase motif has been proposed during the preparation of this manuscript (41, 42) . It has been proposed that there exists a novel phosphatase superfamily possessing a common catalytic mechanism and consisting of the mouse 35-kDa PAP, haloperoxidases, acid phosphatases, glucose-6-phosphatase, and many others (41, 42) . Although further work is needed to substantiate the proposed catalytic mechanism, it is clear that the type 2 PAP represents a novel class of phosphatases. Although not tested in the present study, the dephosphorylation of DG pyrophosphate appears to be a common property of various type 2 PAPs, as has been shown for rat liver enzyme (21) and E. coli pgpB gene product (43) . Identification of amino acid residues essential for the PAP activity is urgently needed to define the catalytic mechanisms of these novel phosphatases. In this context, we noted that a part of the sequences of the type 2 PAPs is significantly conserved in the amino acid clusters found in bacterial acid phosphatase family (Fig. 6 ). These acid phosphatases are soluble proteins with approximately 250 amino acid residues. Since the acid phosphatases have no other conserved sequences than the amino acid clusters given in Fig.  6 , these clusters are quite likely included in their catalytic sites. Although similar findings have already been reported (41, 42) , we intend to point out the fact that the majority of the conserved residues reside in the second and third extracellular regions presently assigned to the mammalian PAPs. We therefore cannot rule out the possibility that the type 2 PAPs so far cloned may dephosphorylate extracellular substrates acting as ectoenzymes. Indeed, there are several reports describing ecto-PAP, whose properties are strikingly similar to those of the type 2 PAPs (44, 45) . This intriguing possibility awaits further investigation.
The type 2 PAP purified from rat liver has been shown to posses a broad substrate specificity dephosphorylating a variety of lipid phosphates, including DG pyrophosphate and those derived from sphingolipids (17, 21) . The two PAPs cloned in the present work were also confirmed to have broad substrate specificity, although the ability to degrade sphingosine-1-phosphate could be detected only for PAP-2b. The rat liver enzyme was described to be a 51-53-kDa protein, which became 30 kDa when treated with N-glycanase (25) . The size of the glycosylated liver enzyme does not match those so far estimated for the sequenced PAPs. This may indicate the presence of the third PAP isozyme. However, the fact that we detected only two classes of homologous sequences in the data base searches appears to suggest that there exist only two PAP isozymes in mammalian tissues. If this is the case, the activity to sphingosine-1-phosphate suggests that PAP-2b may be the human counterpart of rat liver enzyme despite the apparent differences in their molecular sizes.
The expression pattern of PAP-2a among human tissues was much more variable when compared with that of PAP-2b, which was expressed relatively ubiquitously. Despite the close relationship to mouse hic 53 clone previously described (27) , the cellular PAP-2a failed to be induced under a variety of experimental conditions including the treatment with H 2 O 2 . FIG. 6 . Sequence comparison of the PAP isozymes and class A bacterial acid phosphatases. The PAP isozymes show a significant similarity to cluster 3292.5 (CRSeq data base), which is the most conserved region of class A bacterial acid phosphatase and apyrase. Identical amino acids conserved in the two gene families are boxed. The putative structural segments assigned to PAP isozymes are indicated as given in Fig. 1 . Accession numbers for Morganella morganii major phosphate-irrepressible acid phosphatase (PHOC MORMO), Providencia stuartiinonspecific acid phosphatase (PHON PROST), Salmonella typhimurium-nonspecific acid phosphatase (PHON SALTY), and Zymomonas mobilis acid phosphatase (PPA ZYMMO) are P28581, P26975, P26976, and P14924, respectively. I, intracellular; TM, transmembrane; and O, extracellular.
